Document Detail


Can succinylcholine be used safely in hyperkalemic patients?
MedLine Citation:
PMID:  12088954     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of succinylcholine in hyperkalemic patients (serum potassium >5.5 mEq/L) is often viewed as relatively contraindicated, although there are no systematic data to define what preoperative potassium level is safe. We retrospectively reviewed more than 40,000 general anesthetics administered over 70 mo in which succinylcholine was given at the induction. This search yielded 38 patients with a preoperative potassium of 5.6 mEq/L or greater. Survival of the anesthetic was 100%, and no dysrhythmias or other major morbidity were documented upon manual review of the intraoperative automated record keeper charts or the patient medical records. These data allow a 95% confidence interval assessment of maximal risk for an event of 7.9%, which is not negligible, but which almost certainly grossly overestimates the risk for patients with moderately increased potassium levels. A prospective trial to definitively assess the safety margin for succinylcholine use in hyperkalemic patients would be difficult. Therefore, these data, taken in the context of a compelling case for rapid intubating conditions without long-term paralysis, suggest safety in succinylcholine use in patients with modest hyperkalemia. IMPLICATIONS: In a review of more than 40,000 general anesthetics in which succinylcholine was given at induction, 38 patients had a preoperative potassium of 5.6 mEq/L or greater. All patients survived the anesthetic with no dysrhythmias or other major morbidity documented. Succinylcholine may be appropriate and safe for use in certain patients with moderate hyperkalemia.
Authors:
Adam J Schow; David A Lubarsky; Ronald P Olson; Tong J Gan
Related Documents :
21342144 - Anticardiolipin antibodies in patients with behcet's disease.
21085024 - Use of flexion and extension radiographs of the cervical spine to rule out acute instab...
21493244 - Biofilms in chronic rhinosinusitis with nasal polyps.
1242194 - Cephalexin-related nephropathy.
6341534 - A longitudinal study of periodontal disease in patients with reduced immunocapacity.
20364574 - Diagnosis of corticosteroid insufficiency in thai patients with septic shock.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  95     ISSN:  0003-2999     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-06-28     Completed Date:  2002-07-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  119-22, table of contents     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Anesthesia*
Child
Child, Preschool
Female
Humans
Hyperkalemia / complications*
Infant
Male
Middle Aged
Neuromuscular Depolarizing Agents / adverse effects*
Potassium / blood
Retrospective Studies
Risk Assessment
Succinylcholine / adverse effects*
Chemical
Reg. No./Substance:
0/Neuromuscular Depolarizing Agents; 306-40-1/Succinylcholine; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Small-dose ketamine improves the postoperative state of depressed patients.
Next Document:  Sevoflurane increases glucose transport in skeletal muscle cells.